Aethlon Medical (NASDAQ:AEMD) Trading 13% Higher

Shares of Aethlon Medical, Inc. (NASDAQ:AEMD) traded up 13% during trading on Wednesday . The stock traded as high as $0.28 and last traded at $0.26, 117,303 shares were traded during trading. A decline of 34% from the average session volume of 178,812 shares. The stock had previously closed at $0.23.

Separately, ValuEngine cut shares of Aethlon Medical from a “buy” rating to a “hold” rating in a research report on Thursday, August 1st.

The firm has a 50-day moving average price of $0.31. The company has a market capitalization of $4.43 million, a price-to-earnings ratio of -0.80 and a beta of 1.20.

Aethlon Medical (NASDAQ:AEMD) last issued its quarterly earnings results on Monday, July 1st. The medical equipment provider reported ($0.09) EPS for the quarter, missing the consensus estimate of ($0.08) by ($0.01). The firm had revenue of $0.08 million for the quarter, compared to analyst estimates of $0.08 million. Sell-side analysts predict that Aethlon Medical, Inc. will post -0.27 earnings per share for the current year.

A number of hedge funds and other institutional investors have recently modified their holdings of the business. Citadel Advisors LLC lifted its holdings in Aethlon Medical by 259.8% in the second quarter. Citadel Advisors LLC now owns 83,533 shares of the medical equipment provider’s stock worth $30,000 after acquiring an additional 60,317 shares during the last quarter. Cobblestone Capital Advisors LLC NY bought a new position in Aethlon Medical in the second quarter worth about $28,000. Finally, Bank of New York Mellon Corp bought a new position in Aethlon Medical in the fourth quarter worth about $50,000. 4.41% of the stock is currently owned by hedge funds and other institutional investors.

Aethlon Medical Company Profile (NASDAQ:AEMD)

Aethlon Medical, Inc, a medical device company, focuses on creating devices that address unmet medical needs in health and biodefense worldwide. The company is developing Aethlon Hemopurifier, a clinical-stage therapeutic device that eliminates life-threatening viruses from the circulatory system of infected individuals.

Read More: What is channel trading?

Receive News & Ratings for Aethlon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aethlon Medical and related companies with's FREE daily email newsletter.